PRO 04 - Liquid Biopsies in Cancer
MODERATOR(S)
Aadel Chaudhuri, MD, PhD - Mayo Clinic
Abhijit Patel, MD, PhD - Yale University
session DESCRIPTION
Liquid biopsy technologies, particularly circulating tumor DNA (ctDNA), are an emerging tool in precision oncology with growing relevance in radiation oncology. This session will focus on the current and near-term clinical applications of ctDNA, including noninvasive tumor genotyping, early cancer detection, and minimal residual disease (MRD) monitoring. Expert physician-scientists will present recent data that highlight the strengths, limitations, and practical considerations for using liquid biopsy in clinical workflows.
learning objectives
- Understand the basics regarding circulating tumor DNA (ctDNA) and liquid biopsy technologies and applications.
- Understand the utility of ctDNA for noninvasive genotyping, early cancer detection, and minimal residual disease detection and monitoring.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
01:00pm - 01:02pm PTSpeaker: Aadel Chaudhuri, MD, PhD - Mayo Clinic, Rochester
-
01:02pm - 01:17pm PTSpeaker: Scott Bratman, MD, PhD - University of Toronto, Toronto
-
01:17pm - 01:32pm PTSpeaker: Aadel Chaudhuri, MD, PhD - Mayo Clinic, Rochester
-
01:32pm - 01:47pm PTSpeaker: Maximilian Diehn, MD, PhD - Stanford University, Stanford
-
01:47pm - 02:00pm PTSpeaker: Abhijit Patel, MD, PhD - Yale University, New Haven